Market Tracker

05/27 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.301
Delayed Data
As of May 27
 +0.0035 / +1.18%
Today’s Change
0.25
Today|||52-Week Range
0.77
-17.08%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.30
Today’s open0.30
Day’s range0.30 - 0.31
Volume842,209
Average volume (3 months)424,854
Market cap$61.7M
Dividend yield--
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)-37.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...+0.01+1.68%
AVIRAviragen Therapeutic...-0.14-8.81%
MSTXMast Therapeutics In...-0.00-1.15%
CAPRCapricor Therapeutic...+0.02+0.60%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts